IRM
Overvalued by 132.6% based on the discounted cash flow analysis.
Market cap | $21.75 Billion |
---|---|
Enterprise Value | $33.46 Billion |
Dividend Yield | $2.5346 (3.41%) |
Earnings per Share | $0.63 |
Beta | 1.1 |
Outstanding Shares | 292,275,668 |
Avg 30 Day Volume | 1,126,989 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 118.06 |
---|---|
PEG | -153.85 |
Price to Sales | 4.21 |
Price to Book Ratio | - |
Enterprise Value to Revenue | 6.11 |
Enterprise Value to EBIT | 30.14 |
Enterprise Value to Net Income | 181 |
Total Debt to Enterprise | 0.36 |
Debt to Equity | 56.38 |
No data
No data